References
- Lucey M. Liver transplantation for alcoholic liver disease: a progress report. Graft. 1999; 2: S73–S79
- O'Malley SS, Jaffe AJ, Chang G, Schottenfeld RS, Meyer RE, Rounsaville B. Naltrexone and coping skills therapy for alcohol dependence: a controlled study. Arch Gen Psychiatry. 1992; 49: 881–887. [PUBMED], [INFOTRIEVE]
- Volpicelli JR, Alterman AI, Hayashida M, O'Brien CP. Naltrexone in the treatment of alcohol dependence. Arch Gen Psychiatry. 1992; 49: 876–880. [PUBMED], [INFOTRIEVE]
- Weinrieb RM, Van Horn DH, Mclellan AT, et al, Alcoholism treatment after liver transplantation: lessons learned from a clinical trial that failed. Psychosomatics. 2001; 42: 110–115. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Levine J, Gordon N, Jones R, Fields H. The narcotic antagonist naloxone enhances clinical pain. Nature. 1978; 272: 826–827. [PUBMED], [INFOTRIEVE]
- Levine J, Gordon N.. Method of administration determines the effect of naloxone on pain. Brain Res. 1986; 365: 377–378. [PUBMED], [INFOTRIEVE], [CROSSREF]
- Kayser V, Besson J, Guilbaud G. Paradoxical effects of low doses of naloxone in experimental models of inflammatory pain. Prog Brain Research. 1988; 77: 301–312
- Berg B, Pettinati H, Volpicelli J. A risk-benefit assessment of naltrexone for the treatment of alcohol dependence. Drug Saf.. 1996; 15: 274–282. [PUBMED], [INFOTRIEVE], [CSA]
- Wolfhagen FH, Sternieri E, Hop WC, Vitale G, Bertolotti M, Van Buuren HR. Oral naltrexone treatment for cholestatic pruritus: a double-blind, placebo-controlled study. Gastroenterology. 1997; 113: 1264–1269. [PUBMED], [INFOTRIEVE], [CSA]